Drax Group (DRX) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
17 Dec, 2025Executive summary
Achieved strong operational and financial performance in 2024, with a 5% increase in adjusted EBITDA to £1.064 billion, driven by higher renewable generation and improved pellet production.
Enhanced shareholder returns with a 12.6% increase in dividends per share, a £300 million share buyback program (c.£150 million complete), and a strengthened balance sheet.
Secured heads-of-terms CFD agreement for Drax Power Station, supporting UK energy security and post-2027 operations.
Upgraded recurring adjusted EBITDA target for FlexGen, pellet production, and biomass generation to £600–700 million post-2027.
Targeting >25% increase in generation, with continued focus on renewables and pellet production.
Financial highlights
Adjusted EBITDA grew 5% year-over-year to £1.064 billion; cash generated from operations reached £1.135 billion.
Net debt reduced to £992 million, with net debt to adjusted EBITDA at 0.9x; total cash and committed facilities at £806 million.
Full-year dividend for 2024 increased by over 12% to £0.26 per share.
£700 million of new debt raised (maturities 2027–2029), £900 million of shorter maturities repaid.
Adjusted basic EPS increased to 128.4p (2023: 119.6p).
Outlook and guidance
Recurring post-2027 adjusted EBITDA targeted at £600–700 million, with FlexGen, Pellet Production, and Biomass Generation each targeting >£250 million, £250 million, and £100–200 million per annum, respectively.
Over £1 billion estimated post-tax operating cash flows expected 2025–2027, underpinned by forward power sales and renewables.
CapEx for 2025 expected in the range of £180–220 million.
Ongoing investment in growth projects, including OCGTs, Cruachan expansion, and data centre development.
Strong forward power hedges with 20 TWh locked in at an average price over £93 through Q1 2027.
Latest events from Drax Group
- Record renewable output, robust cash flow, and major BESS investments drive 2025 strategy.DRX
H2 202526 Feb 2026 - Adjusted EBITDA up 24% to £515m, net debt down, and £300m buyback to begin Q3 2024.DRX
H1 20242 Feb 2026 - 2025 Adj. EBITDA set to exceed expectations, supporting major growth and shareholder returns.DRX
Trading Update11 Dec 2025 - Strong H1-25 results, buyback extension, and new CfD terms boost long-term earnings outlook.DRX
H1 202531 Jul 2025 - Strong 2024 performance, strategic growth in BECCS and renewables, and robust capital returns.DRX
Trading Update13 Jun 2025 - Drax expects 2025 Adj. EBITDA at the top end of consensus, driven by strong operations and contracts.DRX
Q1 20256 Jun 2025 - Drax forecasts top-end 2025 Adj. EBITDA, advances flexible generation, and boosts shareholder returns.DRX
Trading Update6 Jun 2025